Paper808142
Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
Clyde DF. Am J Trop Med Hyg, 1975. Cited by 352 papers, by iCite.
Cite this record
ConductScience Library. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Papers, record 808142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/808142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apicomplexa | Major topic |
| Immunization | Major topic |
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Plasmodium vivax | Major topic |
| Anopheles | |
| Humans | |
| Immunoglobulins | |
| Male | |
| Middle Aged |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00367380 | Evaluation of Reproducibility of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers | Background | ClinicalTrials.gov | |
| NCT01082341 | Immunization of Human Volunteers With P. Vivax Irradiated Sporozoites | Background | ClinicalTrials.gov | |
| NCT01083095 | Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers | Results | ClinicalTrials.gov | |
| NCT04739917 | Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers | Background | ClinicalTrials.gov |
Cited by117
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 352 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39971939 | iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/39971939 | PubMed |
| 39893367 | Controlled human malaria infection: overview and potential application in the evaluation of transmission-blocking interventions in malaria-endemic areas. | Malar J | 2025 | https://conductscience.org/library/papers/39893367 | PubMed |
| 38687615 | Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine. | JCI Insight | 2024 | https://conductscience.org/library/papers/38687615 | PubMed |
| 38656211 | Vaccines and monoclonal antibodies: new tools for malaria control. | Clin Microbiol Rev | 2024 | https://conductscience.org/library/papers/38656211 | PubMed |
| 38307966 | Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites. | Sci Rep | 2024 | https://conductscience.org/library/papers/38307966 | PubMed |
| 37936181 | Comparative analyses of functional antibody-mediated inhibition with anti-circumsporozoite monoclonal antibodies against transgenic Plasmodium berghei. | Malar J | 2023 | https://conductscience.org/library/papers/37936181 | PubMed |
| 37703302 | Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates. | PLoS Negl Trop Dis | 2023 | https://conductscience.org/library/papers/37703302 | PubMed |
| 37571809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 | https://conductscience.org/library/papers/37571809 | PubMed |
| 37198702 | Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. | Trop Med Health | 2023 | https://conductscience.org/library/papers/37198702 | PubMed |
| 37014087 | Memory CD8+ T cell-mediated protection against liver-stage malaria. | Immunol Rev | 2023 | https://conductscience.org/library/papers/37014087 | PubMed |
| 36685545 | The challenges of Plasmodium vivax human malaria infection models for vaccine development. | Front Immunol | 2022 | https://conductscience.org/library/papers/36685545 | PubMed |
| 36558821 | Cryopreservation of Plasmodium Sporozoites. | Pathogens | 2022 | https://conductscience.org/library/papers/36558821 | PubMed |
| 36343566 | Current approaches to malaria vaccines. | Curr Opin Microbiol | 2022 | https://conductscience.org/library/papers/36343566 | PubMed |
| 36159849 | Five decades of clinical assessment of whole-sporozoite malaria vaccines. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159849 | PubMed |
| 36001680 | A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/36001680 | PubMed |
| 35734173 | Innate Immune Responses and P. falciparum CS Repeat-Specific Neutralizing Antibodies Following Vaccination by Skin Scarification. | Front Immunol | 2022 | https://conductscience.org/library/papers/35734173 | PubMed |
| 34376691 | Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection. | NPJ Vaccines | 2021 | https://conductscience.org/library/papers/34376691 | PubMed |
| 33995336 | Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria? | Front Microbiol | 2021 | https://conductscience.org/library/papers/33995336 | PubMed |
| 33481638 | Progress towards the development of a P. vivax vaccine. | Expert Rev Vaccines | 2021 | https://conductscience.org/library/papers/33481638 | PubMed |
| 32664476 | Potential and Limitations of Cross-Protective Vaccine against Malaria by Blood-Stage Naturally Attenuated Parasite. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32664476 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/808142
GET https://conductscience.org/api/papers/v1/808142/cited_by?page=2